# Reliance Life Sciences Private Limited - Inspection Records

Source: https://www.keypedia.com/companies/reliance-life-sciences-private-limited/14b16d70-e482-4647-a231-4eb4a1aab98f

> Inspection records and compliance data for Reliance Life Sciences Private Limited in Navi Mumbai, None. Access full analysis and detailed observations.

---

## Details

- Name: Reliance Life Sciences Private Limited
- FEI Number: 3009510975
- City: Navi Mumbai
- State: None
- Country Name: India
- Address Line 1: Ttc Area Of Midc, R - 282 Dhirubhai Ambani Life Sciences Centre; Thane Belapur Road
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK

## Related Documents

- [483 - Reliance Life Sciences Private Limited - 2026-02-27](https://www.keypedia.com/records/483/reliance-life-sciences-private-limited/43ee35e0-0c20-4849-9f73-a6f046f78841) — source: FDA, date: February 27, 2026
- [483 - Reliance Life Sciences Private Limited - 2026-02-27](https://www.keypedia.com/records/483/reliance-life-sciences-private-limited/47dfda7e-50c5-402d-8722-6d7100a1f1e7) — source: FDA, date: February 27, 2026
- [FDA Inspection 1311632 - Reliance Life Sciences Private Limited - 2026-02-27](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/ccab4917-175f-46db-ad0c-ba158ab3159d) — source: FDA, date: February 27, 2026
- [FDA Inspection 1170339 - Reliance Life Sciences Private Limited - 2022-04-15](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/25bd4384-4ea7-4998-8065-2fb38edb15d1) — classification: No Action Indicated (NAI), source: FDA, date: April 15, 2022
- [FDA Inspection 1113122 - Reliance Life Sciences Private Limited - 2019-11-22](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/b6113606-88ad-4489-b518-74dc92f5f967) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2019
- [FDA Inspection 1070144 - Reliance Life Sciences Private Limited - 2018-10-16](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/f81e0521-c3a6-4bcf-9fb0-651407a13902) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2018
- [FDA Inspection 1047623 - Reliance Life Sciences Private Limited - 2018-01-25](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/97b25c8c-27f6-433b-b21d-d196bf1897c6) — classification: No Action Indicated (NAI), source: FDA, date: January 25, 2018
- [FDA Inspection 1035956 - Reliance Life Sciences Private Limited - 2017-12-13](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/568afd53-47df-4520-baef-a07fc7d6165e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 13, 2017
- [FDA Inspection 940150 - Reliance Life Sciences Private Limited - 2015-08-14](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/31fccf0e-5d28-486d-93c4-e941ab976fbf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 14, 2015
- [FDA Inspection 847082 - Reliance Life Sciences Private Limited - 2013-08-23](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/49d09572-c747-4753-a295-f4c2867c30f1) — classification: Official Action Indicated (OAI), source: FDA, date: August 23, 2013

## Related Companies

- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/ca77117b-0afe-4b51-bdc2-82ee1e242ec8)
- [IDT Australia Ltd.](https://www.keypedia.com/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [West Agro, Inc.](https://www.keypedia.com/companies/west-agro-inc/81d19178-2702-4936-9c7d-9264e476f1c6)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec)
- [New York Blood Center Enterprises](https://www.keypedia.com/companies/new-york-blood-center-enterprises/29bd2008-0b6c-4674-90f5-96ad1caea4db)
- [A. Nelson & Co., Ltd.](https://www.keypedia.com/companies/a-nelson-co-ltd/36fe9f82-7169-47d2-9e57-8ed77942c73d)
- [Merck Serono SA](https://www.keypedia.com/companies/merck-serono-sa/11522eec-8d30-492a-90ba-09b167899bdc)
- [Pharmacia & Upjohn Company LLC](https://www.keypedia.com/companies/pharmacia-upjohn-company-llc/de0a9227-069b-44f4-a9b3-21db78c27480)
- [Shionogi Pharma Co., Ltd.](https://www.keypedia.com/companies/shionogi-pharma-co-ltd/bb3e5dcd-52f9-4971-9747-4c04b63ba0fa)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/b20ef646-d409-4268-af48-ddf4c16f82cc)

## Related Officers

- [Eileen A. Liu](https://www.keypedia.com/people/eileen-a-liu/fa051db4-1242-4181-9af9-5b3cd2de5689)
- [Ashar P. Parikh](https://www.keypedia.com/people/ashar-p-parikh/f5430c51-31c7-44bb-90f7-1ec8ae581343)